(Q34234214)

31 July 2017

1 reference

title

Sodium ferric gluconate complex in the treatment of iron deficiency for patients on dialysis (English)

1 reference

31 July 2017

0 references

S Fishbane

1

1 reference

31 July 2017

J Wagner

series ordinal

2

1 reference

31 July 2017

publication date

1 May 2001

1 reference

American Journal of Kidney Diseases

31 July 2017

published in

1 reference

31 July 2017

volume

37

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

879-883

1 reference

Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980001-0

7 January 2021

Intravenous ferric saccharate as an iron supplement in dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980001-0

7 January 2021

A randomized controlled study of iron supplementation in patients treated with erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980001-0

7 January 2021

Regular low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980001-0

7 January 2021

Economic appraisal of maintenance parenteral iron administration in treatment of anaemia in chronic haemodialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980001-0

7 January 2021

Iron deficiency in maintenance hemodialysis patients: assessment of diagnosis criteria and of three different iron treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980001-0

7 January 2021

Iron management in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980001-0

7 January 2021

Achieving target hematocrit in dialysis patients: new concepts in iron management

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980001-0

7 January 2021

The safety of intravenous iron dextran in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980001-0

7 January 2021

Intravenous Fe-gluconate-Na for iron-deficient patients on hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980001-0

7 January 2021

Effectiveness of intravenous administration of Fe-gluconate-Na complex to maintain adequate body iron stores in hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980001-0

7 January 2021

Percentage of hypochromic red blood cells as predictor of erythropoietic and iron response after i.v. iron supplementation in maintenance haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980001-0

7 January 2021

Correction of uremic iron deficiency anemia in hemodialyzed patients: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980001-0

7 January 2021

Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980001-0

7 January 2021

Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980001-0

7 January 2021

'Oversaturation' of transferrin after intravenous ferric gluconate (Ferrlecit(R)) in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980001-0

7 January 2021

10.1016/S0272-6386(05)80001-0

Identifiers

DOI

1 reference

31 July 2017

1 reference